{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:03:27Z","timestamp":1773813807157,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"South Transdanubian Regional University Knowledge Centre","award":["OMFB-00846\/2005"],"award-info":[{"award-number":["OMFB-00846\/2005"]}]},{"DOI":"10.13039\/501100003074","name":"National Development Agency","doi-asserted-by":"publisher","award":["DA07-DA_TECH_07-2008-0045"],"award-info":[{"award-number":["DA07-DA_TECH_07-2008-0045"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PannonPharma Ltd"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Microbiology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ijmm.2014.08.001","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T13:47:19Z","timestamp":1407851239000},"page":"1077-1085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Re-evaluation of in vitro activity of primycin against prevalent multiresistant bacteria"],"prefix":"10.1016","volume":"304","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7524-5032","authenticated-orcid":false,"given":"P\u00e9ter","family":"Feiszt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyula","family":"Mesty\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5767-9662","authenticated-orcid":false,"given":"Monika","family":"Ker\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orsolya","family":"Dobay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzsanna","family":"Dombr\u00e1di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edit","family":"Urb\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levente","family":"Em\u0151dy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmm.2014.08.001_bib0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1749-6632.2012.06819.x","article-title":"Mechanisms of daptomycin resistance in Staphylococcus aureus: role of cell membrane and cell wall","volume":"1277","author":"Bayer","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0010","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/jac\/dkq083","article-title":"Antibacterial activity of guanidinylated neomycin B- and kanamycin A-derivated amphiphilic lipid conjugates","volume":"65","author":"Bera","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0015","first-page":"136","article-title":"Ebrimycin gel in the treatment of pyodermas and bacterial secondary infections","volume":"35","author":"B\u00edr\u00f3","year":"1987","journal-title":"Ther. Hung."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0020","series-title":"Antimicrobial Agents: Antibacterials and Antifungals","first-page":"1179","article-title":"Primycin","author":"Bryskier","year":"2005"},{"key":"10.1016\/j.ijmm.2014.08.001_bib0025","series-title":"Approved Guideline M26-A","article-title":"Methods for determining bactericidal activity of antimicrobial agents","author":"Clinical and Laboratory Standards Institute","year":"1999"},{"key":"10.1016\/j.ijmm.2014.08.001_bib0030","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard M07-A9","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.ijmm.2014.08.001_bib0035","series-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved Standard M11-A8","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.ijmm.2014.08.001_bib0040","series-title":"Performance standards for antimicrobial susceptibility testing; Informational Supplement M100-S24","author":"Clinical and Laboratory Standards Institute","year":"2014"},{"key":"10.1016\/j.ijmm.2014.08.001_bib0045","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0050","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/jac\/dkg171","article-title":"Antibiotic susceptibility and serotypes of Streptococcus pneumoniae isolates from Hungary","volume":"51","author":"Dobay","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0055","first-page":"259","article-title":"A case report of vancomycin-resistant Enterococcus faecalis colonisation of a femoral wound in central Europe","volume":"4","author":"Dombr\u00e1di","year":"2009","journal-title":"Cent. Eur. J. Med."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/mdr.2011.0014","article-title":"Prevalence of vanC vancomycin-resistant enterococci in the teaching hospitals of the University of Debrecen, Hungary","volume":"18","author":"Dombr\u00e1di","year":"2012","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0065","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jac\/dkn124","article-title":"In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004\u201305 Prospective European Surveillance Initiative","volume":"62","author":"Draghi","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.det.2008.07.004","article-title":"Topical antibiotics in dermatology: emerging patterns of resistance","volume":"27","author":"Elston","year":"2009","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0075","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/S0040-4039(00)96202-6","article-title":"The composition of primycin","volume":"28","author":"Frank","year":"1987","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00689977","article-title":"The mode of action of primycin","volume":"121","author":"Horv\u00e1th","year":"1979","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0085","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ajo.2006.06.030","article-title":"In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates","volume":"142","author":"Kotlus","year":"2006","journal-title":"Am. J. Ophtalmol."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0090","first-page":"77","article-title":"Use of ebrimycin gel in dermatology","volume":"35","author":"M\u00e9sz\u00e1ros","year":"1987","journal-title":"Ther. Hung."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3354\/dao064211","article-title":"Standardization of broth microdilution susceptibility testing method to determine minimum inhibitory concentrations of aquatic bacteria","volume":"64","author":"Miller","year":"2005","journal-title":"Dis. Aquat. Org."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0100","first-page":"563","article-title":"Primycin (Ebrimycin\u00ae) \u2013 a new topical antibiotic","volume":"24","author":"N\u00f3gr\u00e1di","year":"1988","journal-title":"Drugs Today"},{"key":"10.1016\/j.ijmm.2014.08.001_bib0105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1099\/jmm.0.013946-0","article-title":"In vitro interactions between primycin and different statins in their effects against some clinically important fungi","volume":"59","author":"Nyilasi","year":"2010","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000081946","article-title":"Vancomycin tolerance in enterococci","volume":"50","author":"Saribas","year":"2004","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijmm.2014.08.001_bib0115","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.7164\/antibiotics.32.1207","article-title":"Crystallization and antifungal activity of primycin","volume":"32","author":"\u00dari","year":"1979","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ijmm.2014.08.001_bib0120","first-page":"141","article-title":"Antibacterial activity of primycin against multiple strains of Gram-positive bacteria","volume":"33","author":"\u00dari","year":"1986","journal-title":"Acta Microbiol. Hung."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0125","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/1741105b0","article-title":"Primycin, a new antibiotic","volume":"174","author":"V\u00e1lyi-Nagy","year":"1954","journal-title":"Nature"},{"key":"10.1016\/j.ijmm.2014.08.001_bib0130","first-page":"466","article-title":"The toxicology and pharmacology of primycin","volume":"124","author":"V\u00e1lyi-Nagy","year":"1960","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/ja.2009.130","article-title":"Competitive hydrogen bonds associated with the effect of primycin antibiotic on oleic acid as a building block of plasma membranes","volume":"63","author":"Vir\u00e1g","year":"2010","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ijmm.2014.08.001_bib0140","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbamem.2011.09.020","article-title":"Direct in vivo interaction of the antibiotic primycin with the plasma membrane of Candida albicans: an EPR study","volume":"1818","author":"Vir\u00e1g","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijmm.2014.08.001_bib0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1556\/ABiol.63.2012.1.4","article-title":"In vivo direct interaction of the antibiotic primycin on a Candida albicans clinical isolate and its ergosterol-less mutant","volume":"63","author":"Vir\u00e1g","year":"2012","journal-title":"Acta Biol. Hung."},{"key":"10.1016\/j.ijmm.2014.08.001_bib0150","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ja.2011.140","article-title":"Complex formation between primycin and ergosterol: entropy-driven initiation of modification of the fungal plasma membrane structure","volume":"65","author":"Vir\u00e1g","year":"2012","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ijmm.2014.08.001_bib0155","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1128\/AAC.01662-09","article-title":"CEM-101 activity against Gram-positive organisms","volume":"54","author":"Woosley","year":"2010","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["International Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422114001003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422114001003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T20:59:01Z","timestamp":1538341141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438422114001003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1438422114001003"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmm.2014.08.001","relation":{},"ISSN":["1438-4221"],"issn-type":[{"value":"1438-4221","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-evaluation of in vitro activity of primycin against prevalent multiresistant bacteria","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmm.2014.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}